Revvity Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Revvity Inc's ROA in the second quarter of 2026?
Revvity Inc achieved a return on average assets (ROA) of 1.97 % in its second quarter of 2026, which is below Revvity Inc's average return on assets, which stands at 4.58%.

ROA fell compared to the first quarter of 2026, despite the net income growth of 27.27% from the first quarter of 2026.

However, within the Healthcare sector 191 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jul 05 2026 quarter, so far to 1843, from total ROA ranking in the first quarter of 2026 at 2153.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jul 05 2026) II. Quarter	(Apr 05 2026) I. Quarter	(Dec 28 2025) IV. Quarter	(Sep 28 2025) III. Quarter	(Jun 29 2025) II. Quarter
Y / Y Total Assets Change	-1.15 %	-1.58 %	-0.48 %	-5.17 %	-8.26 %
Y / Y Net Income Change	-3.94 %	-3.6 %	3.93 %	-50.56 %	-2.55 %
Net Income (TTM) in million	238	240	241	237	285
Return On Assets (TTM)	1.97 %	1.98 %	1.99 %	1.96 %	2.32 %
RVTY's Total Ranking	# 1843	# 2153	# 1863	# 1758	# 1770
Total Assets (TTM) in million	12,046	11,997	12,168	11,969	12,187
Seq. Total Assets Change	0.41 %	-1.41 %	1.66 %	-1.78 %	-0.02 %
Seq. Net Income Change	27.27 %	-58.6 %	110.85 %	-13.52 %	27.73 %

RVTY's 5 Years Annual ROA >> Back to RVTY Management Effectiveness >> Compare RVTY ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 7
Sector	# 192
Overall	# 1834

Return On Assets Statistics
High	Average	Low
14.63 %	4.58 %	-0.98 %
(Jul 04 2021)		(Mar 31 2013)

Financial Statements
Revvity Inc's Assets	$ 12,046 million	RVTY's Balance sheet
Revvity Inc's Income	$ 52 million	Quarterly RVTY's Income Statement
RVTY's Income by Division		See RVTY's Income by Division

Annual Return On Assets	(Dec 28 2025) FY 2025	(Dec 29 2024) FY 2024	(Dec 31 2023) FY 2023	(Jan 01 2023) FY 2022	(Jan 02 2022) FY 2021
Y / Y Total Assets Change	-0.48 %	-6.5 %	-7.45 %	3.41 %	71.66 %
Total Assets in million	12,168	12,227	13,077	14,130	13,664
Y / Y Net Income Change	-10.79 %	-60.99 %	21.77 %	-39.65 %	29.57 %
Net Income in million	241	270	693	569	943
Annual Return On Assets	1.98 %	2.21 %	5.3 %	4.03 %	6.9 %

RVTY's 5 Years Annual ROA >> Back to RVTY Management Effectiveness >> Compare RVTY ROA to its Competitors

Comment on RVTY's ROA in the fiscal year ending 2025

In the fiscal year 2025 Revvity Inc's ROA decreased compared to previous year to 1.98 %, due to deterioration of net income -10.79 % to $241.20 million, from $270.39 million a year ago, as RVTY's assets were $12,168.41 million.

More Return On Assets Ratios
RVTY's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
RVTY's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for RVTY's Competitors
Subscribers only: Roa for Revvity Inc's Suppliers
Subscribers only: Return On Assets for RVTY's Customers

You may also want to know
RVTY's Roi	RVTY's Inventory Turnover Ratio	RVTY's Growth Rates	RVTY's Dividend Comparisons
	RVTY's Profitability Ratios	RVTY's Asset Turnover Ratio	RVTY's Dividend Growth
RVTY's Roe	RVTY's Valuation Ratios	RVTY's Financial Strength Ratios	RVTY's Dividend Payout Ratio

Companies with similar Return On Assets at Jul 05 2026, within Healthcare Sector	ROA
Labcorp Holdings Inc	5.40 %
Merit Medical Systems Inc	5.34 %
Sotera Health Company	5.03 %
Vericel Corporation	5.02 %
Kewaunee Scientific Corporation	4.96 %
Pacs Group Inc	4.78 %
Amphastar Pharmaceuticals Inc	4.70 %
Abbvie Inc	4.68 %
The Cooper Companies Inc	4.57 %
IMPACT BIOMEDICAL INC.	4.47 %
Nrc Health	4.31 %
Cadre Holdings inc	4.29 %
The Pennant Group Inc	4.14 %
U S Physical Therapy Inc	4.08 %
Haemonetics Corporation	3.99 %
Henry Schein Inc	3.79 %
Integer Holdings Corporation	3.76 %
Zimmer Biomet Holdings Inc	3.51 %
Ardent Health Inc	3.22 %
Community Health Systems Inc	3.17 %
Vaso Corporation	2.92 %
Collegium Pharmaceutical Inc	2.72 %
National Vision Holdings Inc	2.53 %
Conmed Corporation	2.44 %
Merck and Co Inc	2.42 %
Privia Health Group Inc	2.41 %
Lifestance Health Group Inc	2.33 %
Bio rad Laboratories Inc	2.21 %
Pfizer Inc	2.12 %
Mimedx Group Inc	1.99 %

Date modified: 2026-09-26T07:19:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.